Capitalization 8.19B 9.17B 1.18B 1B 927M 867M 1.62B 108B 1.71B 10.6B 4.21B 51.03B 4.41B 4.32B 186B P/E ratio 2025 *
15.3x
P/E ratio 2026 * 10.6x
Enterprise value 15.24B 17.07B 2.19B 1.86B 1.73B 1.61B 3.01B 201B 3.19B 19.72B 7.83B 94.94B 8.21B 8.04B 345B EV / Sales 2025 *
1.07x
EV / Sales 2026 * 0.96x
Free-Float
32.57%
Yield 2025 *
3.16%
Yield 2026 * 3.65%
More valuation ratios * Estimated data
Dynamic Chart
01-09 China Regulators to Improve Oversight of Infant Formula Products MT
12-23 Health and Happiness International Grants Over 13 Million Share Options MT
11-19 Biostime Delicious Fruity Bites Pack Vitamins, Prebiotics & Probiotics in A Tasty Gummy with Less Than 1 G of Sugar; Make Daily Wellness Fun & Easy for Kids CI
11-18 Health and Happiness (H&H) International posts 9M total revenue RMB10,805.3 million RE
11-18 Health and Happiness (H&H) International Holdings Limited Reports Unaudited Consolidated Revenue Results for the Nine Months Ended 30 September 2025 CI
28/08/25 Jefferies Adjusts Health and Happiness (H&H) International Holdings' Price Target to HK$16 From HK$11.30, Keeps at Buy MT
27/08/25 Health and Happiness (H&H) International Holdings Limited, H1 2025 Earnings Call, Aug 27, 2025
26/08/25 Health and Happiness (H&H) International Holdings Limited Announces Interim Dividend for the Six Months Ended 30 June 2025, Payable on October 17, 2025 CI
26/08/25 Health and Happiness International's Profit Slides 77% in H1 MT
26/08/25 Health and Happiness (H&H) International Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2025 CI
26/08/25 Health and Happiness (H&H) International declares interim dividend of HKD0.19 per share RE
04/07/25 Health and Happiness International's H1 Revenue Sees Mid-Single-Digit Growth MT
12/05/25 Health and Happiness (H&H) International Holdings Limited Approves Final Dividend for the Year Ended 31 December 2024 CI
More news

Last Transcript: Health and Happiness (H&H) International Holdings Limited

1 day+1.36%
1 week+6.04%
Current month+8.31%
1 month+4.95%
3 months+10.16%
6 months+22.29%
Current year+8.31%
More quotes
1 week 13.1
Extreme 13.1
15.13
1 month 12.97
Extreme 12.97
15.13
Current year 12.97
Extreme 12.97
15.13
1 year 8
Extreme 8
15.18
3 years 7.6
Extreme 7.6
17.04
5 years 6.3
Extreme 6.3
40.2
10 years 6.3
Extreme 6.3
64.5
More quotes
Manager TitleAgeSince
Chief Executive Officer 42 01/12/2023
Director of Finance/CFO 52 03/05/2016
Chief Tech/Sci/R&D Officer 41 01/09/2024
Director TitleAgeSince
Chairman 62 03/01/2011
Director/Board Member 70 12/07/2010
Director/Board Member 61 11/01/2011
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.36%+6.04%+69.57%-11.41% 1.18B
+0.32%-1.42%+51.09%+27.09% 920M
+0.84%+0.06%-21.09%-9.34% 357M
Average +0.84%-0.24%+33.19%+2.11% 817.8M
Weighted average by Cap. +0.89%+0.99%+49.44%+3.32%
See all sector performances

Financials

2025 *2026 *
Net sales 14.2B 15.9B 2.04B 1.73B 1.61B 1.5B 2.8B 187B 2.97B 18.37B 7.29B 88.46B 7.65B 7.49B 322B 15.13B 16.94B 2.17B 1.85B 1.71B 1.6B 2.98B 200B 3.16B 19.57B 7.77B 94.25B 8.15B 7.98B 343B
Net income 536M 600M 76.98M 65.48M 60.69M 56.71M 106M 7.07B 112M 694M 275M 3.34B 289M 283M 12.15B 770M 862M 111M 94.06M 87.19M 81.47M 152M 10.16B 161M 996M 396M 4.8B 415M 406M 17.45B
Net Debt 7.05B 7.89B 1.01B 861M 798M 746M 1.39B 92.99B 1.47B 9.12B 3.62B 43.91B 3.8B 3.72B 160B 6.33B 7.08B 908M 773M 716M 669M 1.25B 83.47B 1.32B 8.18B 3.25B 39.41B 3.41B 3.34B 143B
More financial data * Estimated data
Logo Health and Happiness (H&H) International Holdings Limited
Health and Happiness (H&H) International Holdings Limited, formerly Biostime International Holdings Ltd., is an investment holding company principally engaged in the manufacture and sale of premium pediatric nutritional. The Company operates through five business segments. The Infant Formulas segment is engaged in the production of infant formulas for children under seven years old and milk formulas for expectant and nursing mothers. The Adult Nutrition and Care Products segment is engaged in the production of vitamins, health supplements, skin care and sports nutrition products for adults. The Probiotic Supplements segment is engaged in the production of probiotic supplements. The Dried Baby Food and Nutrition Supplements segment is engaged in the production of dried baby food products made from natural foods, as well as microencapsulated milk calcium chewable tablets. The Baby Care Products segment is engaged in the production of baby care products.
Employees
2,800
More about the company
Date Price Change Volume
23/01/26 14.21 $ +1.36% 1,958,788
22/01/26 14.02 $ +0.94% 1,515,261
21/01/26 13.89 $ -1.14% 2,371,454
20/01/26 14.05 $ +6.28% 8,461,516
19/01/26 13.22 $ -1.34% 544,248

Delayed Quote Hong Kong S.E., January 23, 2026 at 04:08 pm

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
12.69CNY
Average target price
15.34CNY
Spread / Average Target
+20.90%
Consensus

Quarterly revenue - Rate of surprise